Pneumothorax Treatment Market Outlook:
Pneumothorax Treatment Market size was valued at USD 32.89 billion in 2025 and is expected to reach USD 54.6 billion by 2035, expanding at around 5.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of pneumothorax treatment is evaluated at USD 34.43 billion.
The growth of the market is due to the burgeoning occurrence of pneumothorax inside the worldwide population, due to the high prevalence of lung diseases which includes asthma, COPD, cystic fibrosis, tuberculosis, and many more. For instance, studies display that the prevalence of COPD was predicted to be 10% in 2020 for each male and female, or 480 million cases globally. As a result, the high incidence of pneumothorax infection because of rising lung sicknesses in the global populace necessitates a larger marketplace for related treatment, diagnostics, and preventive measures.
In addition, the rising smoking rate in the population would also support the industry and accelerate its expansion during the projection period. According to data published by the World Health Organization, an estimated 36.7% of males and 7.8% of women worldwide smoked tobacco in 2020, making up 22.3% of the global population.
